Methods to decrease blood loss and transfusion requirements for liver transplantation (Q24234278)

26 October 2023

3

Hynek Pikhart

Hynek

Pikhart

1 reference

26 October 2023

6

Brian R Davidson

Brian R

Davidson

1 reference

26 October 2023

Andrew Kenneth Burroughs

5

Andrew K Burroughs

Andrew K

Burroughs

1 reference

26 October 2023

Theodora Pissanou

2

Theodora

Pissanou

1 reference

26 October 2023

Jessica Vaughan

series ordinal

4

author given names

Jessica

author last names

Vaughan

1 reference

Cochrane Database of Systematic Reviews

26 October 2023

language of work or name

1 reference

7 December 2011

0 references

published in

0 references

cites work

Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Antithrombin III supplementation during orthotopic liver transplantation in cirrhotic patients: A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Inhibition by aprotinin of tPA-mediated fibrinolysis during orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Effects of low central venous pressure during preanhepatic phase on blood loss and liver and renal function in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Aprotinin reduces vasoactive medication use during adult liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: a randomized clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Aprotinin in orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Comparison of RBCs and FFP with whole blood during liver transplant surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Improved haemodynamic stability with administration of aprotinin during orthotopic liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Vasopressor administration during liver transplant surgery and its effect on endotracheal reintubation rate in the postoperative period: a prospective, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

The effect of aprotinin on renal function in orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Reduced need for vasopressors in patients receiving aprotinin during orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Activated recombinant factor VII in orthotopic liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Thromboelastography-Guided Transfusion Decreases Intraoperative Blood Transfusion During Orthotopic Liver Transplantation: Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Phase 2, randomized, double-blind, placebo-controlled, multicenter clinical evaluation of recombinant human thrombin in multiple surgical indications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

The use of high dose aprotinin in liver transplantation: The influence on fibrinolysis and blood loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Clinical use of synthetic antifibrinolytic agents during liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Use of antifibrinolytics in orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Pharmacologic methods to reduce perioperative bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Blood conservation in liver transplantation: The role of aprotinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Impact of blood salvage during liver transplantation on reduction in transfusion requirements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Aprotinin: pharmacological reduction of perioperative bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Intraoperative massive transfusion decreases survival after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Alloimmunization to red blood cell antigens affects clinical outcomes in liver transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Use of partial cardiopulmonary bypass during the anhepatic phase of orthotopic liver grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Methods for combining randomized clinical trials: strengths and limitations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

A comparison of aprotinin and lysine analogues in high-risk cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Assessment of risk of bias in randomized clinical trials in surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Piggy-back graft for liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Veno-venous bypass versus none for liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Intraoperative blood transfusion requirement is the main determinant of early surgical re-intervention after orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Transfusion free surgery: single institution experience of 27 consecutive liver transplants in Jehovah's Witnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

A model to predict survival in patients with end-stage liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Requirements for transfusion and postoperative outcomes in orthotopic liver transplantation: a meta-analysis on aprotinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

A comparison of methods to detect publication bias in meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Survival rate changes with transfusion of blood products during liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Multiple treatment comparison meta-analyses: a step forward into complexity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Safety and efficacy of perioperative cell salvage and autotransfusion after coronary artery bypass grafting: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Red blood cell transfusion in liver transplantation: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Intention-to-treat analysis: implications for quantitative and qualitative research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Desmopressin before liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

The aprotinin story--is BART the final chapter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Evaluation of networks of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Liver and intestine transplantation in the United States, 1995-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Estimating required information size by quantifying diversity in random-effects model meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009052.PUB2

10.1002/14651858.CD009052.PUB2

21 January 2018

Identifiers

DOI

0 references

Fatcat ID

release_q4xiggpgnnfo3gp74w5sr2rnn4

0 references